Sinocelltech Group LimitedSSE: 688520

Announcement on Convening the Q3 2024 Performance Briefing

Nov 7, 2024 · Issued by Sinocelltech Group Limited via Shanghai Stock Exchange

Filed with SSE · Nov 7, 2024

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-335

Announcement on Convening the Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Sinocelltech Group Limited on 6ix

Earlier from Sinocelltech

Report for Q3 2024Oct 29, 2024
Announcement on the Company's Voluntary Disclosure of Approval Notice for the Clinical Trial of Recombinant Respiratory Syncytial Virus Vaccine SCTV02 by the Company's Holding SubsidiaryOct 23, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024Sep 7, 2024
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Recombinant Shingles Vaccine SCTV04CSep 6, 2024
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Product SCT520FFSep 3, 2024

Later from Sinocelltech

Notice on Convening the 3rd Extraordinary General Meeting in 2024Dec 14, 2024
Announcement on the Addition of New Office Address and Change of Investor Contact Phone NumberDec 21, 2024
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024Dec 31, 2024
Announcement on Expected Gains in Annual Performance for 2024Jan 18, 2025
Announcement on Preliminary Earnings Estimate for 2024Feb 25, 2025

All Sinocelltech news releases

Follow Sinocelltech into a list and get an email when it puts out news.

Follow Sinocelltech